4-甲基-4'-(三氟甲基)-[1,1'-联苯基]-2-羧酸甲酯 | 649557-33-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-甲基-4'-(三氟甲基)-[1,1'-联苯基]-2-羧酸甲酯
• 英文名称: 4-methyl-4'-trifluoromethylbiphenyl-2-carboxylic acid methyl ester
• 英文别名: Methyl 5-methyl-2-[4-(trifluoromethyl)phenyl]benzoate
• CAS: 649557-33-5
• 化学式: C₁₆H₁₃F₃O₂
• 分子量: 294.273
• InChiKey: ZGPGTHFRGBXKKP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  21
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  4-甲基-4'-(三氟甲基)-[1,1'-联苯基]-2-羧酸甲酯 在 sodium hydroxide 作用下， 以 甲醇 、 水 为溶剂， 反应 6.0h， 生成 5-methyl-2-(p-trifluoromethylphenyl)benzoic acid
  参考文献：
  名称：

  通过缺电子烯烃的区域选择性和立体选择性碘内酯化合成七元内酯。

  摘要：

  内部电子缺陷的烯酸的区域和立体选择性碘内酯化已有报道，这提供了直接访问一系列包含两个连续手性中心的多官能化七元内酯的方法。烯烃上的酯取代基在实现高区域选择性中起关键作用。通过实验和DFT计算证明了这一结果。

  DOI：

  10.1039/c9cc10080f
• 作为产物：
  描述：

  3-甲基苯甲酸甲酯 、 4-三氟甲基苯硼酸 在 bis-triphenylphosphine-palladium(II) chloride 、 sodium carbonate 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 12.0h， 生成 4-甲基-4'-(三氟甲基)-[1,1'-联苯基]-2-羧酸甲酯
  参考文献：
  名称：

  通过缺电子烯烃的区域选择性和立体选择性碘内酯化合成七元内酯。

  摘要：

  内部电子缺陷的烯酸的区域和立体选择性碘内酯化已有报道，这提供了直接访问一系列包含两个连续手性中心的多官能化七元内酯的方法。烯烃上的酯取代基在实现高区域选择性中起关键作用。通过实验和DFT计算证明了这一结果。

  DOI：

  10.1039/c9cc10080f

文献信息

• [EN] ARYL PIPERIDINE DERIVATIVES AS INDUCERS OF LDL-RECEPTOR EXPRESSION FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA<br/>[FR] DERIVES DE PIPERIDINE-ARYLE SERVANT D'INDUCTEURS DE L'EXPRESSION DU RECEPTEUR LDL POUR LE TRAITEMENT DE L'HYPERCHOLESTEROLEMIE
  申请人：GLAXO GROUP LTD

  公开号：WO2004006922A1

  公开（公告）日：2004-01-22

  This invention relates to novel compounds which up-regulate LDL receptor (LDL-r) expression and to processes for their preparation, pharmaceutical compositions containing them and their medical use. More particularly, this invention relates to novel aromatic piperidines of formula (I) and their use in therapy.

  这项发明涉及一种新型化合物，可以上调LDL受体（LDL-r）的表达，并涉及其制备过程、含有它们的药物组合物以及它们的医疗用途。更具体地，这项发明涉及式（I）的新型芳香基哌啶及其在治疗中的应用。
• Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia
  申请人：Bouillot Jeanne Anne Marie

  公开号：US20060052384A1

  公开（公告）日：2006-03-09

  This invention relates to novel compounds which up-regulate LDL receptor (LDL-r) expression and to processes for their preparation, pharmaceutical compositions containing them and their medical use. More particularly, this invention relates to novel aromatic piperidines and their use in therapy.

  本发明涉及一种新型化合物，其上调LDL受体（LDL-r）表达，并涉及其制备过程、含有它们的制药组合物及其医学用途。更具体地说，本发明涉及新型芳香基哌啶及其在治疗中的应用。
• Diaminoindanes as Microsomal Triglyceride Transfer Protein Inhibitors
  作者：Gary M. Ksander、Reynalda deJesus、Andrew Yuan、Cynthia Fink、Michael Moskal、Eric Carlson、Paivi Kukkola、Natalie Bilci、Eli Wallace、Alan Neubert、David Feldman、Therese Mogelesky、Kevin Poirier、Michael Jeune、Ronald Steele、Jong Wasvery、Zouhair Stephan、Edna Cahill、Randy Webb、Aida Navarrete、Warren Lee、Joyce Gibson、Natalya Alexander、Haamid Sharif、Ashok Hospattankar

  DOI：10.1021/jm010294e

  日期：2001.12.1

  The synthesis and biological activities of biarylamide-substituted diaminoindanes as microsomal triglyceride transfer protein (MTP) inhibitors are described. One of the more potent compounds, 8aR, inhibited both the secretion of apoB from Hep G2 cells and the MTP-mediated transfer of triglycerides between synthetic acceptor and donor liposomes with IC50 values of 0.7 and 70 nM, respectively. In normolipidemic rats and dogs, oral administration of 8aR dose-dependently reduced both plasma triglycerides and total cholesterol. Moreover, in rats and dogs, 8aR also prevented the postprandial rise in plasma triglycerides following a bolus administration of a fat load. Because MTP inhibitors decrease very low density lipoprotein assembly in the liver, the potential for hepatic lipid accumulation was evaluated. In normolipidemic rats, hepatic cholesterol and triglyceride contents were dose-dependently increased by 8aR. However, hepatic lipid accumulation resulted in negligible change in total liver weight and was reversible after withdrawal of the compound.
• ARYL PIPERIDINE DERIVATIVES AS INDUCERS OF LDL-RECEPTOR EXPRESSION FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
  申请人：GLAXO GROUP LIMITED

  公开号：EP1539158A1

  公开（公告）日：2005-06-15
• Remote and Selective C(sp²)–H Olefination for Sequential Regioselective Linkage of Phenanthrenes
  作者：Yi Wei、Abing Duan、Pan-Ting Tang、Jia-Wei Li、Rou-Ming Peng、Zheng-Xin Zhou、Xiao-Peng Luo、Mohamedally Kurmoo、Yue-Jin Liu、Ming-Hua Zeng

  DOI：10.1021/acs.orglett.0c01208

  日期：2020.6.5

  Biphenylcarboxylic acid with two competing C(sp(2))-H sites was designed for site selective C(sp(2))-H functionalization by developing carboxylic acids assisted remote and selective olefination via 7-membered palladacycle. Mechanism investigation and DFT calculations reveal a kinetics-determined process, which could be utilized to explore a variety of remote site selectivity. The practicability of this method was highlighted by the precise construction of phenathrene under sequential site selectivity.